BioSpace News Archive

Harpoon Therapeutics, Inc (“Harpoon”), a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases, today presented preclinical data supporting the development of a new Protease-activated Tri-specific T cell Activating Construct (“ProTriTAC”) platform.

Today, the American Heart Association, the world’s leading voluntary organization focused on heart and brain health, and The Paul G. Allen Frontiers Group, a division of the Allen Institute, announced awardees of the American Heart Association-Allen Initiative in Brain Health and Cognitive Impairment, a new collaborative funding initiative launched earlier this year.

Personalis, a leader in advanced genomics for precision oncology, today announced the launch of its universal cancer immunogenomics platform, ImmunoID NeXT™.

SC18 takes place 12 - 15 November, 2018 at the Kay Bailey Hutchinson Convention Center in Dallas

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced clinical data from a Phase 1 study of ARO-AAT, the company’s second generation subcutaneously administered RNA interference (RNAi) therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin (AAT) deficiency

The Pennsylvania Department of Military and Veterans Affairs (DMVA) has extended the deadline for the 2018-19 Veterans’ Trust Fund (VTF) grant cycle

Companies specializing in medical devices, digital health, and therapeutics were among the 59 companies that presented their four-minute business plan presentations at the Texas Life Science Forum hosted by the Rice Alliance for Technology and Entrepreneurship and BioHouston and TMC Innovation at the BioScience Research Collaborative in Houston, Nov. 8.

Partnership creates affordable homeownership in North Chicago

The number of tick-borne related illnesses have increased significantly in the last decade. According to the CDC, there has been a three-fold increase in disease cases from infected mosquitos, ticks and fleas in the US from 2004 to 2016.

IBBL (Integrated BioBank of Luxembourg) celebrates this quarter the 10th anniversary of its creation.